<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AJS</journal-id>
<journal-id journal-id-type="hwp">amjsports</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Sports Med</journal-id>
<journal-title>The American Journal of Sports Medicine</journal-title>
<issn pub-type="ppub">0363-5465</issn>
<issn pub-type="epub">1552-3365</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0363546512461596</article-id>
<article-id pub-id-type="publisher-id">10.1177_0363546512461596</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>3</subject>
<subject>41</subject>
<subject>42</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Extracorporeal Shockwave Therapy for Treatment of Delayed Tendon-Bone Insertion Healing in a Rabbit Model</article-title>
<subtitle>A Dose-Response Study</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chow</surname><given-names>Dick Ho Kiu</given-names></name>
<degrees>MPhil</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Suen</surname><given-names>Pui Kit</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fu</surname><given-names>Lai Hong</given-names></name>
<degrees>MPhil</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cheung</surname><given-names>Wing Hoi</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Leung</surname><given-names>Kwok Sui</given-names></name>
<degrees>MD, FRCS</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wong</surname><given-names>Margaret Wan Nar</given-names></name>
<degrees>MD, FRCS</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Qin</surname><given-names>Ling</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0363546512461596">*</xref>
<xref ref-type="corresp" rid="corresp1-0363546512461596">†</xref>
</contrib>
</contrib-group>
<aff id="aff1-0363546512461596"><label>*</label>Musculoskeletal Research Laboratory, Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China</aff>
<aff id="aff2-0363546512461596">Investigation performed at the Musculoskeletal Research Laboratory, Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China</aff>
<author-notes>
<corresp id="corresp1-0363546512461596"><label>†</label>Ling Qin, Musculoskeletal Research Laboratory, Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China (e-mail: <email>qin@ort.cuhk.edu.hk</email>).</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2012</year>
</pub-date>
<volume>40</volume>
<issue>12</issue>
<fpage>2862</fpage>
<lpage>2871</lpage>
<permissions>
<copyright-statement>© 2012 The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American Orthopaedic Society for Sports Medicine</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0363546512461596">
<title>Background:</title>
<p>Tendon–bone insertion (TBI) consists of both hard and soft tissues. TBI injury with delayed repair is not uncommon. High-dose extracorporeal shockwave (ESW) is effective for treating nonunion fracture, whereas low-dose ESW is used for tendinopathy therapy. The dosing effect of ESW on delayed TBI healing is lacking.</p>
</sec>
<sec id="section2-0363546512461596">
<title>Hypothesis:</title>
<p>Low-dose ESW might have a healing enhancement effect comparable to that of high-dose ESW in treating delayed TBI healing.</p>
</sec>
<sec id="section3-0363546512461596">
<title>Study Design:</title>
<p>Controlled laboratory study.</p>
</sec>
<sec id="section4-0363546512461596">
<title>Methods:</title>
<p>Partial patellectomy was adopted to create a delayed TBI healing model by shielding the healing interface between tendon and bone. Ninety-six female New Zealand White rabbits with unilateral delayed TBI healing at the knee joint were divided into 3 groups: controls, low-dose ESW (LD-ESW; 0.06 mJ/mm<sup>2</sup>, 4 Hz, 1500 impulses), and high-dose ESW (HD-ESW; 0.43 mJ/mm<sup>2</sup>, 4 Hz, 1500 impulses). The TBI shielding was removed at week 4 after partial patellectomy, followed by treatment with control or ESW at week 6. The rabbits were euthanized at week 8 and week 12 for radiological, microarchitectural, histological, and mechanical assessments of healing tissues.</p>
</sec>
<sec id="section5-0363546512461596">
<title>Results:</title>
<p>Radiologically, both the LD-ESW group and the HD-ESW group showed larger new bone area than the controls at week 8 and week 12. Microarchitectural measurements showed that the LD-ESW and HD-ESW groups had larger new bone volume than the controls at week 12. Histological assessments confirmed osteogenesis enhancement. Both the LD-ESW and HD-ESW groups showed significantly higher failure load at the TBI healing complex than the control group at week 12. No significant difference was detected between the 2 ESW treatment groups at week 8 or week 12.</p>
</sec>
<sec id="section6-0363546512461596">
<title>Conclusion:</title>
<p>Extracorporeal shockwave, a unique noninvasive physical modality, had similar effects between the low and high dose for treating delayed TBI healing.</p>
</sec>
<sec id="section7-0363546512461596">
<title>Clinical Relevance:</title>
<p>Low-dose ESW for TBI delayed healing might be more desirable and have better compliance in clinical applications.</p>
</sec>
</abstract>
<kwd-group>
<kwd>extracorporeal shock wave therapy (ESW)</kwd>
<kwd>delayed healing</kwd>
<kwd>tendon–bone insertion repair</kwd>
<kwd>dosage</kwd>
<kwd>energy flux density</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Tendon–bone insertion (TBI) is a unique structure that serves as an interface for force transmission from tendon to bone as well as a stress absorber during mechanical loading.<sup><xref ref-type="bibr" rid="bibr46-0363546512461596">46</xref></sup> However, injuries around the TBI are common in athletes, who undergo routine training and competitions.<sup><xref ref-type="bibr" rid="bibr5-0363546512461596">5</xref>,<xref ref-type="bibr" rid="bibr8-0363546512461596">8</xref>,<xref ref-type="bibr" rid="bibr10-0363546512461596">10</xref></sup> Chronic injuries and delayed healing of TBI are often observed, as TBI has limited reparative ability compared with healing that takes place within homogeneous tissues, such as in bone-to-bone and tendon-to-tendon healing. This limitation is attributed to the poor regenerative potential of the fibrocartilage zone at the TBI.<sup><xref ref-type="bibr" rid="bibr20-0363546512461596">20</xref><xref ref-type="bibr" rid="bibr21-0363546512461596"/>-<xref ref-type="bibr" rid="bibr22-0363546512461596">22</xref></sup> To mimic the clinical situation involving delayed repair of TBI, a delayed TBI healing model was recently developed by shielding the tendon–bone healing interface at the initial stage of healing.<sup><xref ref-type="bibr" rid="bibr52-0363546512461596">52</xref></sup></p>
<p>To improve TBI healing, strategies have been developed for its postoperative healing enhancement, such as application of biological agents, biomaterials, cell or gene therapy, and biophysical stimulation.<sup><xref ref-type="bibr" rid="bibr1-0363546512461596">1</xref>,<xref ref-type="bibr" rid="bibr12-0363546512461596">12</xref>,<xref ref-type="bibr" rid="bibr19-0363546512461596">19</xref>,<xref ref-type="bibr" rid="bibr27-0363546512461596">27</xref>,<xref ref-type="bibr" rid="bibr39-0363546512461596">39</xref>,<xref ref-type="bibr" rid="bibr46-0363546512461596">46</xref>,<xref ref-type="bibr" rid="bibr56-0363546512461596">56</xref></sup> Low-intensity pulsed ultrasound (LIPUS) and extracorporeal shock wave (ESW) are 2 commonly used, nonoperative biophysical modalities. The advantage of ESW over LIPUS is that ESW requires a single treatment, whereas LIPUS is to be applied daily.<sup><xref ref-type="bibr" rid="bibr26-0363546512461596">26</xref>,<xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref></sup> Extracorporeal shockwave has been reported to enhance bone fracture healing, including treatment of delayed fracture union or nonunion,<sup><xref ref-type="bibr" rid="bibr6-0363546512461596">6</xref>,<xref ref-type="bibr" rid="bibr42-0363546512461596">42</xref></sup> and tendon healing.<sup><xref ref-type="bibr" rid="bibr48-0363546512461596">48</xref>,<xref ref-type="bibr" rid="bibr54-0363546512461596">54</xref></sup> Our recent studies showed that a single high dose of ESW was able to promote osteogenesis, regeneration of the fibrocartilage zone, and tissue remodeling in delayed TBI healing.<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref>,<xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref></sup></p>
<p>Extracorporeal shockwave energy can be adjusted to study its dosing effects, as energy dose was found to be a better reference for determining the shock wave effect.<sup><xref ref-type="bibr" rid="bibr40-0363546512461596">40</xref></sup> The ESW energy dose is the product of the energy flux density of ESW and the number of shocks applied (energy dose = energy flux density × number of shocks).<sup><xref ref-type="bibr" rid="bibr40-0363546512461596">40</xref></sup> The energy flux density is categorized into low (&lt;0.08 mJ/mm<sup>2</sup>), medium (0.08-0.28 mJ/mm<sup>2</sup>), and high (&gt;0.28 mJ/mm<sup>2</sup>).<sup><xref ref-type="bibr" rid="bibr34-0363546512461596">34</xref></sup> High-dose ESW is often used for nonunion bone fracture treatment,<sup><xref ref-type="bibr" rid="bibr4-0363546512461596">4</xref>,<xref ref-type="bibr" rid="bibr6-0363546512461596">6</xref></sup> whereas low-dose ESW is used for tendinopathy therapy.<sup><xref ref-type="bibr" rid="bibr44-0363546512461596">44</xref></sup> Tendon–bone insertion is a special structure that is composed of multiple tissues, including not only soft tissue (tendon) and hard tissue (bone), but also fibrocartilage, which functions as an interface to bridge these 2 tissues. Therefore, it is desirable to investigate whether low-dose ESW treatment would be as effective as high-dose ESW for its application in treatment of delayed TBI healing. To answer this clinically relevant question, this study was designed to confirm the dosing effects of ESW on TBI healing enhancement, with respect to radiological, histomorphological, and mechanical assessments using our established delayed TBI healing model in rabbits.</p>
<sec id="section8-0363546512461596" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section9-0363546512461596">
<title>Delayed TBI Healing Model</title>
<p>Ninety-six 18-week-old female New Zealand White rabbits were obtained from the Laboratory Animal Service Center of the Chinese University of Hong Kong after animal experimental ethics approval was obtained (Ref. No. 11/042/MIS). Partial patellectomy with shielding at the tendon–bone healing interface was performed on all rabbits according to an established protocol to mimic delayed TBI healing.<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref>,<xref ref-type="bibr" rid="bibr52-0363546512461596">52</xref>,<xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref></sup> Briefly, a transverse osteotomy was performed between the proximal two-thirds and distal one-third of the patella of the left knee by using an oscillating saw (Synthes; Mathys AG, Bettlach, Switzerland). The distal third of the patella and the fibrocartilage zone in the patella were transected. Two sagittal tunnels with a diameter of 0.8 mm were drilled from the osteotomy surface toward the superior pole of the patellar tendon. A Bunnell tendon suture was applied to the patellar tendon using PDS II suture (3/0 PDS II; Ethicon Ltd, Edinburgh, UK).<sup><xref ref-type="bibr" rid="bibr13-0363546512461596">13</xref></sup> Then, a 3 × 2-mm rectangular latex sheet (Ansell Medical, Victoria, Australia) was placed between the remaining proximal patellar segment and the patellar tendon. The 2 ends of the suture were passed through the latex sheet and 2 patellar tunnels. The patellar tendon and the latex sheet were pulled toward and secured against the proximal patella. The suture was then tied at the proximal end of the patella. Before the wound was closed, figure-of-8 tension band wiring (0.6-mm diameter stainless steel wire; Synthes) was applied around the proximal pole of the patella to the tibial tuberosity to protect the suture from overstretching (<xref ref-type="fig" rid="fig1-0363546512461596">Figure 1A</xref>). After the surgery, cast immobilization was applied for 4 weeks. The latex sheet was surgically removed from the tendon–bone healing interface at the end of week 4. Buprenorphine (0.03 mg/kg intramuscularly; Temgesic, Schering-Plough, Kenilworth, New Jersey) was injected 15 minutes before the operation and then daily for 3 days after the operation. The rabbits were allowed free cage activities and food access throughout the experiment.</p>
<fig id="fig1-0363546512461596" position="float">
<label>Figure 1.</label>
<caption><p>(A) The delayed-healing rabbit model with a latex sheet placed between the tendon and the patella for 4 weeks after the partial patellectomy. The latex sheet was then removed 4 weeks after the surgery. Figure-of-8 tension band wire was applied around the proximal pole of the patella to the tibial tuberosity to protect overstretching of the healing complex. (B) A custom-made jig for tensile test of the quadriceps–patella–patellar tendon–tibia healing complex. This testing jig consisted of an upper clamp that fastened the patella together with the distal quadriceps, and a lower clamp that gripped the proximal tibia.</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig1.tif"/>
</fig>
<p>Two fluorochromes, calcein green (10 mg/kg; Sigma, Deisenhofen, Germany) and xylenol orange (90 mg/kg; Sigma), were injected subcutaneously at weeks 2 and 1 before euthanasia, respectively, for histological assessment of the rate of new bone formation. The rabbits were euthanized at the end of week 8 or week 12 after partial patellectomy with an intravenous injection of an overdose of sodium pentobarbital. The figure-of-8 tension band wires were removed, and the quadriceps–patella–patellar tendon–tibia (QPPTT) complex of the operated knee was harvested. The samples were wrapped in gauze with saline, sealed in a freezer bag, and stored in a −80°C freezer for further assessments.</p>
</sec>
<sec id="section10-0363546512461596">
<title>ESW Treatment</title>
<p>The rabbits were randomly divided into 3 groups: controls, low-dose ESW (LD-ESW; 0.06 mJ/mm<sup>2</sup>, 4 Hz, 1500 impulses), and high-dose ESW (HD-ESW; 0.43 mJ/mm<sup>2</sup>, 4 Hz, 1500 impulses). The current study did not include a medium dose because a previous in vitro study did not show significance between medium (0.27 mJ/mm<sup>2</sup>) and high (0.50 mJ/mm<sup>2</sup>) doses of ESW with respect to cell viability.<sup><xref ref-type="bibr" rid="bibr40-0363546512461596">40</xref></sup> A single treatment of ESW was applied at week 6. The rabbits were sedated with an intramuscular injection of ketamine (50 mg/kg) and xylazine (10 mg/kg). The operated knee of the rabbits in the ESW groups was flexed at 90°, and ESW was delivered onto the TBI healing interface using a shockwave machine (Dornier MedTech Epos, Wessling, Germany) according to an established protocol.<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref>,<xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref></sup> Rabbits in the control group were also sedated and placed in the same position for 6 minutes without any ESW treatment.</p>
<p>A total of 96 rabbits were used for the current study; 48 rabbits were sacrificed at week 8, and another 48 rabbits were sacrificed at week 12. Sixteen rabbits from each group at each time point were used for radiographic and μCT analysis before further division for subsequent mechanical testing (n = 8) and histological assessments (n = 8).</p>
</sec>
<sec id="section11-0363546512461596">
<title>Radiological Assessments</title>
<p>After the QPPTT complex was harvested, anteroposterior radiographs of the PPTT complex were taken with an x-ray machine for small animals (Faxitron X-ray Corp, Wheeling, Illinois). The exposure time was set for 3 seconds with tube voltage of 60 kVp. The x-ray source–object distance was 40 cm. Films were digitized (16-bit grayscale, 600 dpi, JPEG format) using a scanner (Epson Perfection V700 Photo Scanner, Epson America, Long Beach, California). New bone area distal to the osteotomy region of the patellar–patellar tendon (PPT) was measured by a single examiner using an image analysis system (Image Pro Plus version 5.1, Media Cybernetics, Inc, Bethesda, Maryland).<sup><xref ref-type="bibr" rid="bibr26-0363546512461596">26</xref>,<xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref></sup> The intraobserver error of the repeated measurements of new bone area from the anterior–posterior radiographs was measured according to an established protocol and found to be 8%.<sup><xref ref-type="bibr" rid="bibr43-0363546512461596">43</xref></sup></p>
</sec>
<sec id="section12-0363546512461596">
<title>μCT Analysis</title>
<p>Microarchitecture of the newly formed bone was evaluated using a high-resolution μCT (μCT-40; Scanco Medical, Brüttisellen, Switzerland) according to an established protocol.<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref></sup> The samples were placed in the sample holder with their long axes in the vertical position. The whole PPT complex was scanned at an isotropic resolution of 20 μm<sup><xref ref-type="bibr" rid="bibr3-0363546512461596">3</xref></sup>. The data were then convoluted with a 3D Gaussian filter with a width and support equal to 1.2 and 2, respectively. Bone was segmented from the marrow and soft tissue for subsequent analysis using a global threshold, which was set to equal 210. Values equal to or greater than the threshold were used for representing bone tissue, whereas values below the threshold represented bone marrow and soft tissue.<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref>,<xref ref-type="bibr" rid="bibr55-0363546512461596">55</xref></sup> The region of interest of the new bone was separated from the remaining patella by the osteotomy site. Bone volume (BV), bone volume density, tissue volume (TV), and the ratio of bone volume to tissue volume (BV/TV) were measured and evaluated.</p>
</sec>
<sec id="section13-0363546512461596">
<title>Mechanical Testing</title>
<p>The tensile strength was mechanically evaluated as the end point assessment of quality of the TBI healing. The QPPTT complex was thawed overnight at 4°C. The metal tension band wire, suture material, all periarticular connective soft tissues, and soft tissues around the knee were removed. The QPPTT complex was mounted onto a custom-made fixator (<xref ref-type="fig" rid="fig1-0363546512461596">Figure 1B</xref>). A Hounsfield test machine (H25K-S, Hounsfield Test Equipment Ltd, Surrey, UK) with a 2.5-kN load cell was used, and a constant tensile load of 1 N was applied to the QPPTT complex. The thickness and width of the PPT junction was measured with a fine caliper, and the cross-sectional area of the tendon–bone healing interface was calculated. This value was used to normalize the tensile force (failure load) for calculating tensile strength or ultimate stress.<sup><xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref>,<xref ref-type="bibr" rid="bibr57-0363546512461596">57</xref></sup> Normal saline was applied to the QPPTT complex to prevent dehydration of the tissue. A load cell of 2.5 kN was used for recording tensile loading at a testing speed of 100 mm/min up to failure of the QPPTT complex.</p>
</sec>
<sec id="section14-0363546512461596">
<title>Histological Assessment</title>
<p>The tibia and distal quadriceps muscle were removed from the QPPTT complex to obtain the PPT complex for fixation in 4% paraformaldehyde solution and then cut into halves along its midsagittal plane using a thin blade saw. One-half of the sample was used for decalcified histology, and the other half was used for undecalcified histology. For decalcified histology, the PPT complex samples were decalcified with ethylenediaminetetraacetic acid for 4 weeks and embedded in paraffin. Serial 5-μm thin sections from the midsagittal plane of each specimen were cut with a microtome. The sections were then stained with hematoxylin and eosin (H&amp;E) or toluidine blue with fast green counterstain for general histological evaluation and assessment of the proteoglycan content of the regenerated fibrocartilage.</p>
<p>For undecalcified histology, the PPT complex was dehydrated in ethanol (70%, 95%, and 100%) and xylene. Then the sample was embedded in methylmethacrylate according to an established protocol.<sup><xref ref-type="bibr" rid="bibr19-0363546512461596">19</xref></sup> The embedded samples were sectioned sagittally (10-μm thickness) using Polycut (Leica Microsystems Cambridge Ltd, Cambridge, UK). The sections were then mounted on gelatin-coated glass slides.</p>
<p>Undecalcifed sections were analyzed under fluorescence microscopy (Leica Q500MC, Leica Microsystems Cambridge Ltd) to investigate the dynamics of osteogenesis, mineralization of new bone and its remodeling. The area of new bone labeled with the fluorochromes was visualized and measured using L5 (calcein green only) and CY5 (xylenol orange only) filters. The ratio of the areas labeled with xylenol orange to the area labeled with calcein green was calculated and interpreted as temporal change in new bone formation.<sup><xref ref-type="bibr" rid="bibr26-0363546512461596">26</xref></sup></p>
</sec>
<sec id="section15-0363546512461596">
<title>Statistical Analysis</title>
<p>All measurements were expressed as mean ± standard deviation (SD). All analyses were performed using SPSS (version 16.0 for Windows, SPSS Inc, Chicago, Illinois). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test was used to detect differences among the 3 groups, including 2 different ESW doses and the control group. Statistical significance was set at <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section16-0363546512461596" sec-type="results">
<title>Results</title>
<p>All the rabbits were sacrificed without showing any adverse effect from surgery or ESW treatment at the TBI healing interface.</p>
<sec id="section17-0363546512461596">
<title>Radiographic Analysis</title>
<p>From the anterior-posterior radiographs, the new bone area was significantly larger in both the LD-ESW group (62.1%, <italic>P</italic> = .02 at week 8 and 66.1%, <italic>P</italic> = .003 at week 12) and the HD-ESW group (75.4%, <italic>P</italic> = .02 at week 8 and 61.7%, <italic>P</italic> =.003 at week 12) (<xref ref-type="table" rid="table1-0363546512461596">Table 1</xref> and <xref ref-type="fig" rid="fig2-0363546512461596">Figure 2</xref>) than that of the control group compared for the same healing time point. The new bone area in all groups showed an increase of 93%, 98%, and 78% from week 8 to week 12 in the control, LD-ESW, and HD-ESW groups, respectively, yet without showing dosing effects in both ESW treatment groups (<xref ref-type="fig" rid="fig2-0363546512461596">Figure 2</xref>).</p>
<table-wrap id="table1-0363546512461596" position="float">
<label>Table 1</label>
<caption><p>Tendon–Bone Insertion Repair Compared Among ESW Treatment Groups and the Control Group</p></caption>
<graphic alternate-form-of="table1-0363546512461596" xlink:href="10.1177_0363546512461596-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">Control Group<hr/></th>
<th align="center" colspan="2">Low-dose ESW Group<hr/></th>
<th align="center" colspan="2">High-dose ESW Group<hr/></th>
</tr>
<tr>
<th/>
<th align="center">Week 8 (n = 8)</th>
<th align="center">Week 12 (n = 8)</th>
<th align="center">Week 8 (n = 8)</th>
<th align="center">Week 12 (n = 8)</th>
<th align="center">Week 8 (n = 8)</th>
<th align="center">Week 12 (n = 8)</th>
</tr>
</thead>
<tbody>
<tr>
<td>New bone area, mm<sup>2</sup></td>
<td>2.80 ± 0.71</td>
<td>5.412 ± 1.269</td>
<td>4.54 ± 0.63<sup><xref ref-type="table-fn" rid="table-fn1-0363546512461596"><italic>a</italic></xref></sup></td>
<td>8.99 ± 2.31<sup><xref ref-type="table-fn" rid="table-fn2-0363546512461596"><italic>b</italic></xref></sup></td>
<td>4.91 ± 1.24<sup><xref ref-type="table-fn" rid="table-fn1-0363546512461596"><italic>a</italic></xref></sup></td>
<td>8.75 ± 2.63<sup><xref ref-type="table-fn" rid="table-fn2-0363546512461596"><italic>b</italic></xref></sup></td>
</tr>
<tr>
<td>New bone volume, mm<sup>3</sup>
</td>
<td>8.88 ± 2.83</td>
<td>10.14 ± 4.29</td>
<td>8.47 ± 1.32</td>
<td>19.76 ± 4.90</td>
<td>9.017 ± 3.367</td>
<td>23.82 ± 9.51<sup><xref ref-type="table-fn" rid="table-fn1-0363546512461596"><italic>a</italic></xref></sup></td>
</tr>
<tr>
<td>Bone volume to tissue volume</td>
<td>0.75 ± 0.13</td>
<td>0.75 ± 0.06</td>
<td>0.81 ± 0.04</td>
<td>0.82 ± 0.06</td>
<td>0.72 ± 0.11</td>
<td>0.84 ± 0.04</td>
</tr>
<tr>
<td>Bone volume density, mg HA/cm<sup>3</sup>
</td>
<td>658.05 ± 25.66</td>
<td>665.49 ± 50.31</td>
<td>632.23 ± 49.33</td>
<td>624.68 ± 67.88</td>
<td>657.52 ± 87.98</td>
<td>679.69 ± 24.79</td>
</tr>
<tr>
<td>Failure load, N</td>
<td>159.83 ± 27.49</td>
<td>154.65 ± 36.01</td>
<td>171.70 ± 42.23</td>
<td>202.53 ± 31.14<sup><xref ref-type="table-fn" rid="table-fn1-0363546512461596"><italic>a</italic></xref></sup></td>
<td>170.65 ± 57.92</td>
<td>200.65 ± 36.69<sup><xref ref-type="table-fn" rid="table-fn1-0363546512461596"><italic>a</italic></xref></sup></td>
</tr>
<tr>
<td>Ultimate strength, mPa</td>
<td>4.99 ± 0.54</td>
<td>5.07 ± 1.47</td>
<td>4.78 ± 1.51</td>
<td>6.50 ± 2.02</td>
<td>4.89 ± 1.97</td>
<td>6.64 ± 1.27</td>
</tr>
<tr>
<td>Ratio of bone-forming area</td>
<td>1.03 ± 0.06</td>
<td>1.07 ± 0.08</td>
<td>1.13 ± 0.11</td>
<td>1.27 ± 0.06<sup><xref ref-type="table-fn" rid="table-fn2-0363546512461596"><italic>b</italic></xref></sup></td>
<td>1.18 ± 0.11</td>
<td>1.31 ± 0.10<sup><xref ref-type="table-fn" rid="table-fn2-0363546512461596"><italic>b</italic></xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0363546512461596">
<label>a</label>
<p>Statistical significance compared with the control group at the same time point: <italic>P</italic> &lt; .05.</p>
</fn>
<fn id="table-fn2-0363546512461596">
<label>b</label>
<p>Statistical significance compared with the control group at the same time point: <italic>P</italic> &lt; .01.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-0363546512461596" position="float">
<label>Figure 2.</label>
<caption><p>New bone area compared among the 2 ESW groups and the control group at week 8 and week 12. *<italic>P</italic> &lt; .05; **<italic>P</italic> &lt; .01, compared with the control group at the same healing time point; n =16 for each group and time point.</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig2.tif"/>
</fig>
</sec>
<sec id="section18-0363546512461596">
<title>Microarchitectural Analysis</title>
<p>The 3-dimensional (3D) reconstruction of the patella by μCT showed that the LD-ESW and HD-ESW groups obviously had more new bone formation compared with the results from the control group at the TBI healing interface at both week 8 and week 12 (<xref ref-type="table" rid="table1-0363546512461596">Table 1</xref> and <xref ref-type="fig" rid="fig3-0363546512461596">Figure 3</xref>). The new bone volume in the LD-ESW and HD-ESW groups was 94.9% (<italic>P</italic> &gt; .05) and 135% (<italic>P</italic> = .03), respectively, larger than that of the control group at week 12 (<xref ref-type="fig" rid="fig4-0363546512461596">Figure 4</xref>). New bone volume of the control, LD-ESW, and HD-ESW groups increased by 14.2%, 133.4%, and 164.1%, respectively, from week 8 to week 12. However, the difference in new bone area and volume at both week 8 and week 12 was not statistically significant between the LD-ESW and HD-ESW groups. Bone volume to tissue volume and the density of the new bone did not show any statistically significant difference among the 3 groups at both week 8 and week 12 (<xref ref-type="table" rid="table1-0363546512461596">Table 1</xref>). Moreover, there was a limited increase in BV/TV in the 2 ESW treatment groups and the control group from week 8 to week 12 (<xref ref-type="table" rid="table1-0363546512461596">Table 1</xref>).</p>
<fig id="fig3-0363546512461596" position="float">
<label>Figure 3.</label>
<caption><p>Representative 3-dimensional μCT images of the proximal patella of the 2 ESW groups and the control group at week 8 and week 12. The white arrow indicates the osteotomy site. Both ESW treatment groups show comparable new bone formation at the healing interface at both week 8 and week 12, whereas minimal bone formation was observed in the control group for both healing time points. Sample size: n = 16 for each group and time point.</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig3.tif"/>
</fig>
<fig id="fig4-0363546512461596" position="float">
<label>Figure 4.</label>
<caption><p>New bone volume was measured by μCT and compared among 2 different ESW groups and the control group at week 8 and week 12. HD-ESW showed significantly larger new bone volume compared with that of the control group at week 12. *<italic>P</italic> &lt; .05 compared with the control group at the same healing time point; n = 16 for each group and time point.</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig4.tif"/>
</fig>
</sec>
<sec id="section19-0363546512461596">
<title>Histological Assessments</title>
<sec id="section20-0363546512461596">
<title>Decalcified Histology</title>
<p>The TBI healing quality in the ESW-treated groups advanced significantly as compared with the control group. At week 8, scar tissue was present in the TBI healing interface and limited new bone was formed in the control group, whereas the LD-ESW and HD-ESW groups showed significantly larger new bone area (<xref ref-type="fig" rid="fig5-0363546512461596">Figure 5</xref>). At week 12, the control group showed more new bone at the TBI healing interface compared with that at week 8 (<xref ref-type="fig" rid="fig5-0363546512461596">Figure 5</xref>), however, there was no observable fibrocartilage zone formation (<xref ref-type="fig" rid="fig6-0363546512461596">Figure 6</xref>). In the TBI healing interface of the ESW-treated groups at week 12, more lamellar bone within the new bone was found, whereas the TBI fibrocartilage zone was regenerated and present between the tendon–bone healing interface (<xref ref-type="fig" rid="fig6-0363546512461596">Figure 6</xref> and <xref ref-type="fig" rid="fig7-0363546512461596">Figure 7</xref>). Proteoglycan deposition at the TBI healing interface of the ESW-treated groups was greater than that of the control group at week 12 (<xref ref-type="fig" rid="fig7-0363546512461596">Figure 7</xref>).</p>
<fig id="fig5-0363546512461596" position="float">
<label>Figure 5.</label>
<caption><p>Representative midsagittal sections of tendon–bone insertion (TBI) healing interface of the 2 ESW-treated groups and the control group at week 8 and week 12. The dotted line represents the osteotomy site. Enhanced new bone formation is observed in both the LD-ESW group and the HD-ESW group as compared with that of the control group, at both week 8 and week 12 (H&amp;E staining, 16× magnification, scale bar = 2 mm).</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig5.tif"/>
</fig>
<fig id="fig6-0363546512461596" position="float">
<label>Figure 6.</label>
<caption><p>Representative histological sections at week 12. The fibrocartilage zone is not obvious in the control group, whereas this zone is significantly larger in the LD-ESW and HD-ESW groups. B, bone; FC, fibrocartilage; T, tendon (H&amp;E staining, 100× magnification).</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig6.tif"/>
</fig>
<fig id="fig7-0363546512461596" position="float">
<label>Figure 7.</label>
<caption><p>Representative week 12 sample sections stained with toluidine blue. The toluidine blue staining shows the deposition of proteoglycan, which is a noncollagenous matrix protein found in fibrocartilage. The fibrocartilage zone is not obvious in the control group, whereas this zone is significantly larger in the LD-ESW and HD-ESW groups. B, bone; FC, fibrocartilage; T, tendon (toludine blue staining, 100× magnification).</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig7.tif"/>
</fig>
</sec>
<sec id="section21-0363546512461596">
<title>Undecalcified Histology</title>
<p>Sequential fluorescence-labeled sections taken using different filters (<xref ref-type="fig" rid="fig8-0363546512461596">Figure 8</xref>) showed that the rate of new bone formation in both the LD-ESW and HD-ESW group was significantly higher than that of the control group at week 12 (<xref ref-type="fig" rid="fig9-0363546512461596">Figure 9A</xref>). However, there was no significant difference between the LD-ESW group and the HD-ESW group at both week 8 and week 12 (<xref ref-type="fig" rid="fig9-0363546512461596">Figure 9A</xref>). The ratio of the bone-forming rate was significantly higher in both the LD-ESW and HD-ESW groups than the control group at week 12 (<italic>P</italic> = .008 and <italic>P</italic> = .005, respectively) (<xref ref-type="fig" rid="fig9-0363546512461596">Figure 9B</xref>).</p>
<fig id="fig8-0363546512461596" position="float">
<label>Figure 8.</label>
<caption><p>Dynamics of osteogenesis as determined using fluorochrome labeling. The fluorochromes were injected 2 weeks (calcein green, panel A, taken by L5 filter) and 1 week (xylenol orange, panel B, taken by CY5 filter) before euthanasia. New bone formation was calculated by comparing the area of new bone measured under the L5 and CY5 filter (panel C).</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig8.tif"/>
</fig>
<fig id="fig9-0363546512461596" position="float">
<label>Figure 9.</label>
<caption><p>New bone formation at the tendon–bone healing interface. (A) Representative fluorochrome images of the ESW-treated groups and the control group, which show the dynamic process of bone formation at the patella–patellar tendon healing complex. (B) Bone-forming area ratio compared among the 2 ESW groups and the control group at week 8 and week 12. This ratio is calculated by dividing the area of new bone measured under the CY5 filter (red) by the area of new bone measured under the L5 filter (green). New bone area ratio &gt;1 represents an increased rate of bone formation, whereas a ratio &lt;1 represents decreased rate of bone formation. **<italic>P</italic> &lt; .01 compared with the control group at the same healing time point; n = 8 for each group and time point.</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig9.tif"/>
</fig>
</sec>
</sec>
<sec id="section22-0363546512461596">
<title>Mechanical Testing</title>
<p>The overall healing quality of the TBI healing interface was assessed with respect to the tensile properties (<xref ref-type="table" rid="table1-0363546512461596">Table 1</xref>). The failure load of the 2 ESW treatment groups improved significantly as compared with that of the control group (<xref ref-type="fig" rid="fig10-0363546512461596">Figure 10</xref>). Both the LD-ESW group and HD-ESW group showed 30.9% (<italic>P</italic> = .04) and 37.7% (<italic>P</italic> = .04) higher failure load than the control group at week 12, respectively, yet without showing significant differences at either failure load (<xref ref-type="fig" rid="fig10-0363546512461596">Figure 10</xref>) or ultimate strength (<xref ref-type="table" rid="table1-0363546512461596">Table 1</xref>) between the 2 ESW-treated groups.</p>
<fig id="fig10-0363546512461596" position="float">
<label>Figure 10.</label>
<caption><p>Tendon–bone healing improved with ESW treatment. Failure load compared among the 2 ESW groups and the control group at week 8 and week 12. *Significant difference compared with the control (<italic>P</italic> &lt; .05); n = 8 for each group and time point.</p></caption>
<graphic xlink:href="10.1177_0363546512461596-fig10.tif"/>
</fig>
</sec>
</sec>
<sec id="section23-0363546512461596" sec-type="discussion">
<title>Discussion</title>
<p>The current study was designed to investigate the dosing effects of ESW on the treatment of delayed TBI healing using our established rabbit model. The conventional 2D radiological and advanced 3D μCT analysis, as well as histological and mechanical testing, showed the efficacy of ESW treatment on delayed TBI healing enhancement, yet without revealing dose-dependent effects.</p>
<p>The present study showed that low-dose ESW was as effective as high-dose ESW in the promotion of healing in a delayed TBI healing model in rabbits. Randomized controlled studies that investigated the dosage effect of ESW on shoulder tendinopathies also found no significant difference between low-dose and high-dose ESW. For ESW treatment of chronic calcifying tendinitis of the rotator cuff, Seil et al<sup><xref ref-type="bibr" rid="bibr37-0363546512461596">37</xref></sup> did not find a significant difference in Constant score and visual analog scale between the patients treated with ESW with an energy flux density of 0.04-0.12 mJ/mm<sup>2</sup> and the patients treated with ESW with energy flux density &gt;0.12 mJ/mm<sup>2</sup>. With respect to shoulder pain, Loew et al<sup><xref ref-type="bibr" rid="bibr24-0363546512461596">24</xref></sup> performed a cohort study and found that there was no difference in outcome between individuals who received the same number of shocks at 0.2 mJ/mm<sup>2</sup> or 0.3 mJ/mm<sup>2</sup>. In a clinical study on patients with chronic patellar tendinopathy, Wang et al<sup><xref ref-type="bibr" rid="bibr48-0363546512461596">48</xref></sup> compared ESW with conservative treatment and found that ESW (0.18 mJ/mm<sup>2</sup>) effectively enhanced healing with less recurrence of symptoms and an increase in vascularity of the patellar tendon. In addition, other clinical studies that used the different doses of ESW (0.06-0.44 mJ/mm<sup>2</sup>) also showed that ESW was effective for treating patellar tendinopathy.<sup><xref ref-type="bibr" rid="bibr29-0363546512461596">29</xref>,<xref ref-type="bibr" rid="bibr44-0363546512461596">44</xref>,<xref ref-type="bibr" rid="bibr45-0363546512461596">45</xref></sup> Therefore, the difference in ESW dosage might not be detectable in vivo, either experimentally or clinically, as compared with our previous in vitro results. An in vitro ESW dosage study on human periosteal cells showed that low-intensity ESW (0.12 mJ/mm<sup>2</sup>, 1250 impulses) enhanced cell proliferation, cell viability, and calcium deposition, whereas high-intensity ESW (0.5 mJ/mm<sup>2</sup>, 300 impulses) showed inhibitory effects. Moreover, at the early phase of the treatment, the high-intensity ESW revealed an even more detrimental effect on the viability of human periosteal cells than the low-intensity ESW.<sup><xref ref-type="bibr" rid="bibr40-0363546512461596">40</xref></sup> Others reported that low doses of mechanical stimulation enabled tendon-derived stem cells to differentiate into tenocytes, whereas high doses stimulated the differentiation into adipogenic, chondrogenic, and osteogenic lineages by up-regulating the respective marker genes in vitro.<sup><xref ref-type="bibr" rid="bibr58-0363546512461596">58</xref></sup> Since tenogenic, chondrogenic, and osteogenic cells were present at the TBI healing interface and participated in the repair of TBI, different dosages of ESW might have different effects on the healing tissues at the TBI healing complex. However, because of the design of the current study, potential differences in the in vivo biological processes during TBI healing were not differentiated.</p>
<p>Extracorporeal shockwave treatment enhanced the healing quality of the delayed TBI repair by enhancing osteogenesis at the TBI healing interface. Both the LD-ESW group and the HD-ESW group showed enhanced osteogenesis in radiological and histological assessments when compared with the control group at both week 8 and week 12. Enhancement in new bone formation in TBI repair was also observed in our previous biophysical intervention studies.<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref>,<xref ref-type="bibr" rid="bibr53-0363546512461596">53</xref></sup> The enhancement of osteogenesis in our in vivo experiment was supported by in vitro studies as well. Extracorporeal shockwave enhanced calcium deposition,<sup><xref ref-type="bibr" rid="bibr40-0363546512461596">40</xref></sup> up-regulated genes involved in osteoblast differentiation and skeletal development,<sup><xref ref-type="bibr" rid="bibr15-0363546512461596">15</xref></sup> and enhanced differentiation of bone-marrow stromal cells toward osteoprogenitors.<sup><xref ref-type="bibr" rid="bibr50-0363546512461596">50</xref></sup> This enhanced osteogenesis at the TBI healing interface by ESW might also account for the enhanced mechanical properties of the TBI healing complex, as both new bone area and length have been reported to be correlated with the tensile strength of the TBI healing complex.<sup><xref ref-type="bibr" rid="bibr25-0363546512461596">25</xref></sup> The exact mechanism of ESW for the improved repair quality of TBI requires further investigation. The mechanism might be related to the ESW-induced microdamage to the fibrotic tissues at the healing interface that prevented the normal healing process and up-regulation of extracellular cytokines and growth factors for healing enhancement, such as vascular endothelial growth factor,<sup><xref ref-type="bibr" rid="bibr31-0363546512461596">31</xref>,<xref ref-type="bibr" rid="bibr47-0363546512461596">47</xref>,<xref ref-type="bibr" rid="bibr49-0363546512461596">49</xref></sup> bone morphogenic proteins,<sup><xref ref-type="bibr" rid="bibr49-0363546512461596">49</xref>,<xref ref-type="bibr" rid="bibr51-0363546512461596">51</xref></sup> and transforming growth factor β (TGF-β).<sup><xref ref-type="bibr" rid="bibr7-0363546512461596">7</xref>,<xref ref-type="bibr" rid="bibr49-0363546512461596">49</xref>,<xref ref-type="bibr" rid="bibr50-0363546512461596">50</xref></sup></p>
<p>Treatment with ESW enhanced the regeneration of fibrocartilage and proteoglycan deposition. From the histological sections, the presence of chondrocytes, tidemark that separates the calcified and uncalcified fibrocartilage, and the deposition of proteoglycan suggested that the fibrocartilage zone was regenerated in the current delayed-healing model, that is, after removal of the fibrocartilage zone after the partial patellectomy. The potential mechanisms associated with regeneration of the fibrocartilage zone might be related to the recruitment of a number of noncartilage progenitor cells. The possible cell sources would be the bone marrow–derived stem cells, tendon-derived stem cells, or adipose-derived stem cells.<sup><xref ref-type="bibr" rid="bibr3-0363546512461596">3</xref>,<xref ref-type="bibr" rid="bibr23-0363546512461596">23</xref>,<xref ref-type="bibr" rid="bibr28-0363546512461596">28</xref></sup> Since application of ESW to fibroblasts in vitro increased the expression of TGF-β1,<sup><xref ref-type="bibr" rid="bibr2-0363546512461596">2</xref></sup> a factor that is involved in migration of mesenchymal stem cells (MSCs),<sup><xref ref-type="bibr" rid="bibr41-0363546512461596">41</xref></sup> proteoglycan synthesis in tendon,<sup><xref ref-type="bibr" rid="bibr33-0363546512461596">33</xref></sup> and chondrogenesis,<sup><xref ref-type="bibr" rid="bibr18-0363546512461596">18</xref>,<xref ref-type="bibr" rid="bibr30-0363546512461596">30</xref></sup> ESW might enhance fibrocartilage regeneration via recruitment of MSCs.</p>
<p>Extracorporeal shockwave enhanced bone regeneration and remodeling at the TBI healing interface without showing a dosing effect. The ratio of bone-forming area, which was measured from sequentially labeled sections, and general histomorphological assessments showed that remodeling of the new bone located at the TBI healing interface was enhanced by 2 different doses of ESW treatment compared with that of the control at both week 8 and week 12. Bone remodeling is the process that modifies the woven bone into lamellar bone in order to enhance the mechanical properties of the newly repaired bone.<sup><xref ref-type="bibr" rid="bibr9-0363546512461596">9</xref></sup> This process consists of bone formation and bone resorption.<sup><xref ref-type="bibr" rid="bibr9-0363546512461596">9</xref></sup> An important process in bone formation is bone mineralization. Ratio of bone-forming area is an index of temporal changes of bone formation and mineralization of 2 consecutive weeks, that is, 1 and 2 weeks before euthanasia of the animals. Histological sections stained with H&amp;E showed that there was more lamellar bone present in the TBI healing interface of the ESW-treated groups, and the ratio of bone-forming area showed enhanced bone mineralization in the ESW-treated groups. Therefore, enhancement of mineralization and presence of lamellar bone at the TBI healing interface of the ESW-treated groups implied the role of ESW in the enhancement of bone remodeling.</p>
<p>Although no ESW dosing effect on new bone formation at the TBI healing interface was detected, low-dose ESW may be more clinically desirable because of fewer adverse side-effects than the high-dose ESW. High-dose ESW (0.60 mJ/mm<sup>2</sup>) applied to the rabbit Achilles tendon caused marked skin erosion and histological changes such as increased eosin staining, fibrinoid necrosis, fibrosis in the paratendon, and infiltration of inflammatory cells.<sup><xref ref-type="bibr" rid="bibr34-0363546512461596">34</xref>,<xref ref-type="bibr" rid="bibr36-0363546512461596">36</xref></sup> Potential adverse effects of ESW treatment, such as pain and reddening of the skin, were found in 4.8% and 21.1%, respectively, of the subjects treated with the low dose of ESW.<sup><xref ref-type="bibr" rid="bibr14-0363546512461596">14</xref></sup> These adverse effects would be even more substantial with high-dose ESW treatment. Therefore, analgesia was often administered for high-dose ESW treatment in order to improve pain management and clinical compliance.<sup><xref ref-type="bibr" rid="bibr14-0363546512461596">14</xref>,<xref ref-type="bibr" rid="bibr16-0363546512461596">16</xref>,<xref ref-type="bibr" rid="bibr32-0363546512461596">32</xref>,<xref ref-type="bibr" rid="bibr35-0363546512461596">35</xref></sup> Low-dose ESW treatment was reported to be less painful and uncomfortable for patients compared with the high-dose ESW, requiring less or no anesthesia during treatment.<sup><xref ref-type="bibr" rid="bibr17-0363546512461596">17</xref>,<xref ref-type="bibr" rid="bibr38-0363546512461596">38</xref></sup> Therefore, the application of low-dose ESW treatment may be more clinically appealing and better tolerated compared with high-dose ESW treatment in TBI repair enhancement.</p>
<p>The current study also had a few limitations. First, there is the difference in knee biomechanics between rabbits and humans. However, the tissue composition and cellular physiology of rabbits closely approximates that of humans.<sup><xref ref-type="bibr" rid="bibr11-0363546512461596">11</xref></sup> Second, although we demonstrated no differences in ESW dosing effects in the current animal experimental study, it is generally recommended to validate such experimental findings, at least clinically, because of the difference in the size of the repair region. Third, there are potential differences in the cause of the disorder. In clinical settings, delayed healing is often caused by general host factors such as diabetes mellitus, smoking, and poor nutritional status, or other local factors such as interruption of local blood supply, imposition of soft tissue in the healing interface, and infections,<sup><xref ref-type="bibr" rid="bibr9-0363546512461596">9</xref></sup> whereas our delayed model focused only on the local factor of the imposition of the latex sheet in the healing interface. Nevertheless, our current experimental model demonstrated the clinical features found in delayed TBI healing such as an excess amount of fibrous tissue overbridging the healing interface, even though other factors can cause delayed healing.<sup><xref ref-type="bibr" rid="bibr9-0363546512461596">9</xref></sup></p>
<p>Future in vivo studies with respect to ESW treatment should focus on the possible cell source(s) that participate in the repair and regeneration of this fibrocartilage zone at the TBI, with a longer observation period toward the full regeneration and potential remodeling of the fibrocartilage zone.</p>
</sec>
<sec id="section24-0363546512461596" sec-type="conclusions">
<title>Conclusion</title>
<p>This study demonstrated that ESW was effective for treating delayed TBI healing, yet without showing evidence of dose-dependency. Therefore, low-dose ESW may be more appreciated than high-dose ESW for clinical use because patients undergoing low-dose ESW treatment experience less pain and discomfort. The results of the current study establish a foundation for designing clinical trials of ESW for the treatment of delayed repair involving the TBI. The results might also be generalized to other problematic TBI healing sites, and successful application in recalcitrant cases might also obviate the need for surgical treatment.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>One or more of the authors has declared the following potential conflict of interest or source of funding: This project was supported by Research Grants Council of the Hong Kong Special Administrative Regions (Ref: CUHK4762/08).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0363546512461596">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Archer</surname><given-names>CW</given-names></name>
<name><surname>Buxton</surname><given-names>P</given-names></name>
<name><surname>Hall</surname><given-names>BK</given-names></name>
<name><surname>Francis-West</surname><given-names>P</given-names></name>
</person-group>. <article-title>Mechanical regulation of secondary chondrogenesis</article-title>. <source>Biorheology</source>. <year>2006</year>;<volume>43</volume>:<fpage>355</fpage>-<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr2-0363546512461596">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berta</surname><given-names>L</given-names></name>
<name><surname>Fazzari</surname><given-names>A</given-names></name>
<name><surname>Ficco</surname><given-names>AM</given-names></name>
<name><surname>Enrica</surname><given-names>PM</given-names></name>
<name><surname>Catalano</surname><given-names>MG</given-names></name>
<name><surname>Frairia</surname><given-names>R</given-names></name>
</person-group>. <article-title>Extracorporeal shock waves enhance normal fibroblast proliferation in vitro and activate mRNA expression for TGF-beta1 and for collagen types I and III</article-title>. <source>Acta Orthop</source>. <year>2009</year>;<volume>80</volume>:<fpage>612</fpage>-<lpage>617</lpage>.</citation>
</ref>
<ref id="bibr3-0363546512461596">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bi</surname><given-names>Y</given-names></name>
<name><surname>Ehirchiou</surname><given-names>D</given-names></name>
<name><surname>Kilts</surname><given-names>TM</given-names></name>
<etal/>
</person-group>. <article-title>Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche</article-title>. <source>Nat Med</source>. <year>2007</year>;<volume>13</volume>:<fpage>1219</fpage>-<lpage>1227</lpage>.</citation>
</ref>
<ref id="bibr4-0363546512461596">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Birnbaum</surname><given-names>K</given-names></name>
<name><surname>Wirtz</surname><given-names>DC</given-names></name>
<name><surname>Siebert</surname><given-names>CH</given-names></name>
<name><surname>Heller</surname><given-names>KD</given-names></name>
</person-group>. <article-title>Use of extracorporeal shock-wave therapy (ESWT) in the treatment of non-unions. A review of the literature</article-title>. <source>Arch Orthop Trauma Surg</source>. <year>2002</year>;<volume>122</volume>:<fpage>324</fpage>-<lpage>330</lpage>.</citation>
</ref>
<ref id="bibr5-0363546512461596">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blevins</surname><given-names>FT</given-names></name>
<name><surname>Hayes</surname><given-names>WM</given-names></name>
<name><surname>Warren</surname><given-names>RF</given-names></name>
</person-group>. <article-title>Rotator cuff injury in contact athletes</article-title>. <source>Am J Sports Med</source>. <year>1996</year>;<volume>24</volume>:<fpage>263</fpage>-<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr6-0363546512461596">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bulut</surname><given-names>O</given-names></name>
<name><surname>Eroglu</surname><given-names>M</given-names></name>
<name><surname>Ozturk</surname><given-names>H</given-names></name>
<name><surname>Tezeren</surname><given-names>G</given-names></name>
<name><surname>Bulut</surname><given-names>S</given-names></name>
<name><surname>Koptagel</surname><given-names>E</given-names></name>
</person-group>. <article-title>Extracorporeal shock wave treatment for defective nonunion of the radius: a rabbit model</article-title>. <source>J Orthop Surg (Hong Kong)</source>. <year>2006</year>;<volume>14</volume>:<fpage>133</fpage>-<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr7-0363546512461596">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>YJ</given-names></name>
<name><surname>Wurtz</surname><given-names>T</given-names></name>
<name><surname>Wang</surname><given-names>CJ</given-names></name>
<etal/>
</person-group>. <article-title>Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats</article-title>. <source>J Orthop Res</source>. <year>2004</year>;<volume>22</volume>:<fpage>526</fpage>-<lpage>534</lpage>.</citation>
</ref>
<ref id="bibr8-0363546512461596">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cook</surname><given-names>JL</given-names></name>
<name><surname>Khan</surname><given-names>KM</given-names></name>
<name><surname>Kiss</surname><given-names>ZS</given-names></name>
<name><surname>Griffiths</surname><given-names>L</given-names></name>
</person-group>. <article-title>Patellar tendinopathy in junior basketball players: a controlled clinical and ultrasonographic study of 268 patellar tendons in players aged 14-18 years</article-title>. <source>Scand J Med Sci Sports</source>. <year>2000</year>;<volume>10</volume>:<fpage>216</fpage>-<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr9-0363546512461596">
<label>9.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Einhorn</surname><given-names>TA</given-names></name>
<name><surname>Simon</surname><given-names>SR</given-names></name>
</person-group>. <source>Orthopaedic Basic Science: Biology and Biomechanics of the Musculoskeletal System</source>. <edition>2nd ed.</edition> <publisher-loc>Rosemont, IL</publisher-loc>: <publisher-name>American Academy of Orthopaedic Surgeons</publisher-name>; <year>2000</year>.</citation>
</ref>
<ref id="bibr10-0363546512461596">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fordham</surname><given-names>S</given-names></name>
<name><surname>Garbutt</surname><given-names>G</given-names></name>
<name><surname>Lopes</surname><given-names>P</given-names></name>
</person-group>. <article-title>Epidemiology of injuries in adventure racing athletes</article-title>. <source>Br J Sports Med</source>. <year>2004</year>;<volume>38</volume>:<fpage>300</fpage>-<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr11-0363546512461596">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fox</surname><given-names>RR</given-names></name>
</person-group>. <article-title>The rabbit as a research subject</article-title>. <source>Physiologist</source>. <year>1984</year>;<volume>27</volume>:<fpage>393</fpage>-<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr12-0363546512461596">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>García-Álvarez</surname><given-names>F</given-names></name>
<name><surname>Alegre-Aguarón</surname><given-names>E</given-names></name>
<name><surname>Desportes</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Chondrogenic differentiation in femoral bone marrow-derived mesenchymal cells (MSC) from elderly patients suffering osteoarthritis or femoral fracture</article-title>. <source>Arch Gerontol Geriatr</source>. <year>2011</year>;<volume>52</volume>:<fpage>239</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr13-0363546512461596">
<label>13.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Green</surname><given-names>DP</given-names></name>
</person-group>. <source>Green's Operative Hand Surgery</source>. <edition>5th ed.</edition> <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Elsevier/Churchill Livingstone</publisher-name>; <year>2005</year>.</citation>
</ref>
<ref id="bibr14-0363546512461596">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haake</surname><given-names>M</given-names></name>
<name><surname>Boddeker</surname><given-names>IR</given-names></name>
<name><surname>Decker</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Side-effects of extracorporeal shock wave therapy (ESWT) in the treatment of tennis elbow</article-title>. <source>Arch Orthop Trauma Surg</source>. <year>2002</year>;<volume>122</volume>:<fpage>222</fpage>-<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr15-0363546512461596">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hofmann</surname><given-names>A</given-names></name>
<name><surname>Ritz</surname><given-names>U</given-names></name>
<name><surname>Hessmann</surname><given-names>MH</given-names></name>
<name><surname>Alini</surname><given-names>M</given-names></name>
<name><surname>Rommens</surname><given-names>PM</given-names></name>
<name><surname>Rompe</surname><given-names>J-D</given-names></name>
</person-group>. <article-title>Extracorporeal shock wave-mediated changes in proliferation, differentiation, and gene expression of human osteoblasts</article-title>. <source>J Trauma</source>. <year>2008</year>;<volume>65</volume>:<fpage>1402</fpage>-<lpage>1410</lpage>.</citation>
</ref>
<ref id="bibr16-0363546512461596">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krischek</surname><given-names>O</given-names></name>
<name><surname>Hopf</surname><given-names>C</given-names></name>
<name><surname>Nafe</surname><given-names>B</given-names></name>
<name><surname>Rompe</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Shock-wave therapy for tennis and golfer's elbow–1 year follow-up</article-title>. <source>Arch Orthop Trauma Surg</source>. <year>1999</year>;<volume>119</volume>:<fpage>62</fpage>-<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr17-0363546512461596">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Labek</surname><given-names>G</given-names></name>
<name><surname>Auersperg</surname><given-names>V</given-names></name>
<name><surname>Ziernhold</surname><given-names>M</given-names></name>
<name><surname>Poulios</surname><given-names>N</given-names></name>
<name><surname>Bohler</surname><given-names>N</given-names></name>
</person-group>. <article-title>Influence of local anesthesia and energy level on the clinical outcome of extracorporeal shock wave-treatment of chronic plantar fasciitis [in German]</article-title>. <source>Z Orthop Ihre Grenzgeb</source>. <year>2005</year>;<volume>143</volume>:<fpage>240</fpage>-<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr18-0363546512461596">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JW</given-names></name>
<name><surname>Kim</surname><given-names>YH</given-names></name>
<name><surname>Kim</surname><given-names>S-H</given-names></name>
<name><surname>Han</surname><given-names>SH</given-names></name>
<name><surname>Hahn</surname><given-names>SB</given-names></name>
</person-group>. <article-title>Chondrogenic differentiation of mesenchymal stem cells and its clinical applications</article-title>. <source>Yonsei Med J</source>. <year>2004</year>;<volume>45</volume>(<supplement>Suppl</supplement>):<fpage>41</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr19-0363546512461596">
<label>19.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Leung</surname><given-names>KS</given-names></name>
</person-group>. <source>A Practical Manual for Musculoskeletal Research</source>. <publisher-loc>Singapore</publisher-loc>: <publisher-name>World Scientific</publisher-name>; <year>2008</year>.</citation>
</ref>
<ref id="bibr20-0363546512461596">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leung</surname><given-names>KS</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Fu</surname><given-names>LK</given-names></name>
<name><surname>Chan</surname><given-names>CW</given-names></name>
</person-group>. <article-title>A comparative study of bone to bone repair and bone to tendon healing in patella-patellar tendon complex in rabbits</article-title>. <source>Clin Biomech (Bristol, Avon)</source>. <year>2002</year>;<volume>17</volume>:<fpage>594</fpage>-<lpage>602</lpage>.</citation>
</ref>
<ref id="bibr21-0363546512461596">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leung</surname><given-names>KS</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Leung</surname><given-names>MC</given-names></name>
<name><surname>Fu</surname><given-names>LL</given-names></name>
<name><surname>Chan</surname><given-names>CW</given-names></name>
</person-group>. <article-title>Partial patellectomy induces a decrease in the proteoglycan content in the remaining patellar articular cartilage. An experimental study in rabbits</article-title>. <source>Clin Exp Rheumatol</source>. <year>1999</year>;<volume>17</volume>:<fpage>597</fpage>-<lpage>600</lpage>.</citation>
</ref>
<ref id="bibr22-0363546512461596">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>SH</given-names></name>
<name><surname>Panossian</surname><given-names>V</given-names></name>
<name><surname>al-Shaikh</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Morphology and matrix composition during early tendon to bone healing</article-title>. <source>Clin Orthop Relat Res</source>. <year>1997</year>;<volume>339</volume>:<fpage>253</fpage>-<lpage>260</lpage>.</citation>
</ref>
<ref id="bibr23-0363546512461596">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>YP</given-names></name>
<name><surname>Li</surname><given-names>SZ</given-names></name>
<name><surname>Yuan</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Infrapatellar fat pad may be with tendon repairing ability and closely related with the developing process of patella Baja</article-title>. <source>Med Hypotheses</source>. <year>2011</year>;<volume>77</volume>:<fpage>620</fpage>-<lpage>623</lpage>.</citation>
</ref>
<ref id="bibr24-0363546512461596">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Loew</surname><given-names>M</given-names></name>
<name><surname>Daecke</surname><given-names>W</given-names></name>
<name><surname>Kusnierczak</surname><given-names>D</given-names></name>
<name><surname>Rahmanzadeh</surname><given-names>M</given-names></name>
<name><surname>Ewerbeck</surname><given-names>V</given-names></name>
</person-group>. <article-title>Shock-wave therapy is effective for chronic calcifying tendinitis of the shoulder</article-title>. <source>J Bone Joint Surg Br</source>. <year>1999</year>;<volume>81</volume>:<fpage>863</fpage>-<lpage>867</lpage>.</citation>
</ref>
<ref id="bibr25-0363546512461596">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>H</given-names></name>
<name><surname>Hu</surname><given-names>J</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Chan</surname><given-names>KM</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<name><surname>Li</surname><given-names>K</given-names></name>
</person-group>. <article-title>Area, length and mineralization content of new bone at bone-tendon junction predict its repair quality</article-title>. <source>J Orthop Res</source>. <year>2011</year>;<volume>29</volume>:<fpage>672</fpage>-<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr26-0363546512461596">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>H</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Fok</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Low-intensity pulsed ultrasound accelerates bone-tendon junction healing: a partial patellectomy model in rabbits</article-title>. <source>Am J Sports Med</source>. <year>2006</year>;<volume>34</volume>:<fpage>1287</fpage>-<lpage>1296</lpage>.</citation>
</ref>
<ref id="bibr27-0363546512461596">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nixon</surname><given-names>AJ</given-names></name>
<name><surname>Goodrich</surname><given-names>LR</given-names></name>
<name><surname>Scimeca</surname><given-names>MS</given-names></name>
<etal/>
</person-group>. <article-title>Gene therapy in musculoskeletal repair</article-title>. <source>Ann N Y Acad Sci</source>. <year>2007</year>;<volume>1117</volume>:<fpage>310</fpage>-<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr28-0363546512461596">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nourissat</surname><given-names>G</given-names></name>
<name><surname>Diop</surname><given-names>A</given-names></name>
<name><surname>Maurel</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>:<fpage>e12248</fpage>.</citation>
</ref>
<ref id="bibr29-0363546512461596">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peers</surname><given-names>KH</given-names></name>
<name><surname>Lysens</surname><given-names>RJ</given-names></name>
<name><surname>Brys</surname><given-names>P</given-names></name>
<name><surname>Bellemans</surname><given-names>J</given-names></name>
</person-group>. <article-title>Cross-sectional outcome analysis of athletes with chronic patellar tendinopathy treated surgically and by extracorporeal shock wave therapy</article-title>. <source>Clin J Sport Med</source>. <year>2003</year>;<volume>13</volume>:<fpage>79</fpage>-<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr30-0363546512461596">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pogue</surname><given-names>R</given-names></name>
<name><surname>Lyons</surname><given-names>K</given-names></name>
</person-group>. <article-title>BMP signaling in the cartilage growth plate</article-title>. <source>Curr Top Dev Biol</source>. <year>2006</year>;<volume>76</volume>:<fpage>1</fpage>-<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr31-0363546512461596">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Wong</surname><given-names>MW</given-names></name>
<etal/>
</person-group>. <article-title>Osteogenesis induced by extracorporeal shockwave in treatment of delayed osteotendinous junction healing</article-title>. <source>J Orthop Res</source>. <year>2010</year>;<volume>28</volume>:<fpage>70</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr32-0363546512461596">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richter</surname><given-names>D</given-names></name>
<name><surname>Ekkernkamp</surname><given-names>A</given-names></name>
<name><surname>Muhr</surname><given-names>G</given-names></name>
</person-group>. <article-title>Extracorporeal shock wave therapy–an alternative concept for the treatment of epicondylitis of the humerus and radius? [in German]</article-title>. <source>Orthopade</source>. <year>1995</year>;<volume>24</volume>:<fpage>303</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr33-0363546512461596">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Robbins</surname><given-names>JR</given-names></name>
<name><surname>Evanko</surname><given-names>SP</given-names></name>
<name><surname>Vogel</surname><given-names>KG</given-names></name>
</person-group>. <article-title>Mechanical loading and TGF-beta regulate proteoglycan synthesis in tendon</article-title>. <source>Arch Biochem Biophys</source>. <year>1997</year>;<volume>342</volume>:<fpage>203</fpage>-<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr34-0363546512461596">
<label>34.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Rompe</surname><given-names>J-D</given-names></name>
</person-group>. <source>Shock Wave Applications in Musculoskeletal Disorders</source>. <publisher-loc>Stuttgart, NY</publisher-loc>: <publisher-loc>Thieme</publisher-loc>; <year>2002</year>.</citation>
</ref>
<ref id="bibr35-0363546512461596">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rompe</surname><given-names>JD</given-names></name>
<name><surname>Hope</surname><given-names>C</given-names></name>
<name><surname>Kullmer</surname><given-names>K</given-names></name>
<name><surname>Heine</surname><given-names>J</given-names></name>
<name><surname>Burger</surname><given-names>R</given-names></name>
</person-group>. <article-title>Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow</article-title>. <source>J Bone Joint Surg Br</source>. <year>1996</year>;<volume>78</volume>:<fpage>233</fpage>-<lpage>237</lpage>.</citation>
</ref>
<ref id="bibr36-0363546512461596">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rompe</surname><given-names>JD</given-names></name>
<name><surname>Kirkpatrick</surname><given-names>CJ</given-names></name>
<name><surname>Kullmer</surname><given-names>K</given-names></name>
<name><surname>Schwitalle</surname><given-names>M</given-names></name>
<name><surname>Krischek</surname><given-names>O</given-names></name>
</person-group>. <article-title>Dose-related effects of shock waves on rabbit tendo Achillis. A sonographic and histological study</article-title>. <source>J Bone Joint Surg Br</source>. <year>1998</year>;<volume>80</volume>:<fpage>546</fpage>-<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr37-0363546512461596">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seil</surname><given-names>R</given-names></name>
<name><surname>Rupp</surname><given-names>S</given-names></name>
<name><surname>Hammer</surname><given-names>DS</given-names></name>
<name><surname>Ensslin</surname><given-names>S</given-names></name>
<name><surname>Gebhardt</surname><given-names>T</given-names></name>
<name><surname>Kohn</surname><given-names>D</given-names></name>
</person-group>. <article-title>Extracorporeal shockwave therapy in tendionosis calcarea of the rotator cuff: comparison of different treatment protocols [in German]</article-title>. <source>Z Orthop Ihre Grenzgeb</source>. <year>1999</year>;<volume>137</volume>:<fpage>310</fpage>-<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr38-0363546512461596">
<label>38.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Siebert</surname><given-names>W</given-names></name>
</person-group>. <source>Extracorporeal Shock Waves in Orthopaedics</source>. <publisher-loc>Berlin and New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>1998</year>.</citation>
</ref>
<ref id="bibr39-0363546512461596">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steinert</surname><given-names>AF</given-names></name>
<name><surname>Nöth</surname><given-names>U</given-names></name>
<name><surname>Tuan</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Concepts in gene therapy for cartilage repair</article-title>. <source>Injury</source>. <year>2008</year>;<volume>39</volume>(<supplement>Suppl 1</supplement>):<fpage>S97</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr40-0363546512461596">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tam</surname><given-names>K-F</given-names></name>
<name><surname>Cheung</surname><given-names>W-H</given-names></name>
<name><surname>Lee</surname><given-names>K-M</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Leung</surname><given-names>K-S</given-names></name>
</person-group>. <article-title>Delayed stimulatory effect of low-intensity shockwaves on human periosteal cells</article-title>. <source>Clin Orthop Relat Res</source>. <year>2005</year>;<volume>438</volume>:<fpage>260</fpage>-<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr41-0363546512461596">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tang</surname><given-names>Y</given-names></name>
<name><surname>Wu</surname><given-names>X</given-names></name>
<name><surname>Lei</surname><given-names>W</given-names></name>
<etal/>
</person-group>. <article-title>TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation</article-title>. <source>Nat Med</source>. <year>2009</year>;<volume>15</volume>:<fpage>757</fpage>-<lpage>765</lpage>.</citation>
</ref>
<ref id="bibr42-0363546512461596">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thiel</surname><given-names>M</given-names></name>
</person-group>. <article-title>Application of shock waves in medicine</article-title>. <source>Clin Orthop Relat Res</source>. <year>2001</year>;<volume>387</volume>:<fpage>18</fpage>-<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr43-0363546512461596">
<label>43.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Ulijaszek</surname><given-names>SJ</given-names></name>
<name><surname>Mascie-Taylor</surname><given-names>CGN</given-names></name>
</person-group>. <source>Anthropometry: The Individual and the Population</source>. <publisher-loc>Cambridge, UK and New York, NY</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>; <year>1994</year>.</citation>
</ref>
<ref id="bibr44-0363546512461596">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Leeuwen</surname><given-names>MT</given-names></name>
<name><surname>Zwerver</surname><given-names>J</given-names></name>
<name><surname>van den Akker-Scheek</surname><given-names>I</given-names></name>
</person-group>. <article-title>Extracorporeal shockwave therapy for patellar tendinopathy: a review of the literature</article-title>. <source>Br J Sports Med</source>. <year>2009</year>;<volume>43</volume>:<fpage>163</fpage>-<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr45-0363546512461596">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vulpiani</surname><given-names>MC</given-names></name>
<name><surname>Vetrano</surname><given-names>M</given-names></name>
<name><surname>Savoia</surname><given-names>V</given-names></name>
<name><surname>Di Pangrazio</surname><given-names>E</given-names></name>
<name><surname>Trischitta</surname><given-names>D</given-names></name>
<name><surname>Ferretti</surname><given-names>A</given-names></name>
</person-group>. <article-title>Jumper’s knee treatment with extracorporeal shock wave therapy: a long-term follow-up observational study</article-title>. <source>J Sports Med Phys Fitness</source>. <year>2007</year>;<volume>47</volume>:<fpage>323</fpage>-<lpage>328</lpage>.</citation>
</ref>
<ref id="bibr46-0363546512461596">
<label>46.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Walsh</surname><given-names>WR</given-names></name>
</person-group>. <source>Repair and Regeneration of Ligaments, Tendons, and Joint Capsule</source>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name>; <year>2006</year>.</citation>
</ref>
<ref id="bibr47-0363546512461596">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C-J</given-names></name>
<name><surname>Huang</surname><given-names>K-E</given-names></name>
<name><surname>Sun</surname><given-names>Y-C</given-names></name>
<etal/>
</person-group>. <article-title>VEGF modulates angiogenesis and osteogenesis in shockwave-promoted fracture healing in rabbits</article-title>. <source>J Surg Res</source>. <year>2011</year>;<volume>171</volume>:<fpage>114</fpage>-<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr48-0363546512461596">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C-J</given-names></name>
<name><surname>Ko</surname><given-names>J-Y</given-names></name>
<name><surname>Chan</surname><given-names>Y-S</given-names></name>
<name><surname>Weng</surname><given-names>L-H</given-names></name>
<name><surname>Hsu</surname><given-names>S-L</given-names></name>
</person-group>. <article-title>Extracorporeal shockwave for chronic patellar tendinopathy</article-title>. <source>Am J Sports Med</source>. <year>2007</year>;<volume>35</volume>:<fpage>972</fpage>-<lpage>978</lpage>.</citation>
</ref>
<ref id="bibr49-0363546512461596">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C-J</given-names></name>
<name><surname>Yang</surname><given-names>KD</given-names></name>
<name><surname>Ko</surname><given-names>J-Y</given-names></name>
<name><surname>Huang</surname><given-names>C-C</given-names></name>
<name><surname>Huang</surname><given-names>H-Y</given-names></name>
<name><surname>Wang</surname><given-names>F-S</given-names></name>
</person-group>. <article-title>The effects of shockwave on bone healing and systemic concentrations of nitric oxide (NO), TGF-beta1, VEGF and BMP-2 in long bone non-unions</article-title>. <source>Nitric Oxide</source>. <year>2009</year>;<volume>20</volume>:<fpage>298</fpage>-<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr50-0363546512461596">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>FS</given-names></name>
<name><surname>Yang</surname><given-names>KD</given-names></name>
<name><surname>Chen</surname><given-names>RF</given-names></name>
<name><surname>Wang</surname><given-names>CJ</given-names></name>
<name><surname>Sheen-Chen</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Extracorporeal shock wave promotes growth and differentiation of bone-marrow stromal cells towards osteoprogenitors associated with induction of TGF-beta1</article-title>. <source>J Bone Joint Surg Br</source>. <year>2002</year>;<volume>84</volume>:<fpage>457</fpage>-<lpage>461</lpage>.</citation>
</ref>
<ref id="bibr51-0363546512461596">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>FS</given-names></name>
<name><surname>Yang</surname><given-names>KD</given-names></name>
<name><surname>Kuo</surname><given-names>YR</given-names></name>
<etal/>
</person-group>. <article-title>Temporal and spatial expression of bone morphogenetic proteins in extracorporeal shock wave-promoted healing of segmental defect</article-title>. <source>Bone</source>. <year>2003</year>;<volume>32</volume>:<fpage>387</fpage>-<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr52-0363546512461596">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Cheung</surname><given-names>W-H</given-names></name>
<etal/>
</person-group>. <article-title>A delayed bone-tendon junction healing model established for potential treatment of related sports injuries</article-title>. <source>Br J Sports Med</source>. <year>2010</year>;<volume>44</volume>:<fpage>114</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr53-0363546512461596">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Lu</surname><given-names>H-B</given-names></name>
<etal/>
</person-group>. <article-title>Extracorporeal shock wave therapy in treatment of delayed bone-tendon healing</article-title>. <source>Am J Sports Med</source>. <year>2008</year>;<volume>36</volume>:<fpage>340</fpage>-<lpage>347</lpage>.</citation>
</ref>
<ref id="bibr54-0363546512461596">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weil</surname><given-names>LS</given-names><suffix>Jr</suffix></name>
<name><surname>Roukis</surname><given-names>TS</given-names></name>
<name><surname>Weil</surname><given-names>LS</given-names></name>
<name><surname>Borrelli</surname><given-names>AH</given-names></name>
</person-group>. <article-title>Extracorporeal shock wave therapy for the treatment of chronic plantar fasciitis: indications, protocol, intermediate results, and a comparison of results to fasciotomy</article-title>. <source>J Foot Ankle Surg</source>. <year>2002</year>;<volume>41</volume>:<fpage>166</fpage>-<lpage>172</lpage>.</citation>
</ref>
<ref id="bibr55-0363546512461596">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wen</surname><given-names>C-Y</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Lee</surname><given-names>K-M</given-names></name>
<name><surname>Wong</surname><given-names>MW-N</given-names></name>
<name><surname>Chan</surname><given-names>K-M</given-names></name>
</person-group>. <article-title>Influence of bone adaptation on tendon-to-bone healing in bone tunnel after anterior cruciate ligament reconstruction in a rabbit model</article-title>. <source>J Orthop Res</source>. <year>2009</year>;<volume>27</volume>:<fpage>1447</fpage>-<lpage>1456</lpage>.</citation>
</ref>
<ref id="bibr56-0363546512461596">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname><given-names>MWN</given-names></name>
</person-group>. <article-title>Traumatic tibialis anterior tendon rupture-delayed repair with free sliding tibialis anterior tendon graft</article-title>. <source>Injury</source>. <year>2004</year>;<volume>35</volume>:<fpage>940</fpage>-<lpage>944</lpage>.</citation>
</ref>
<ref id="bibr57-0363546512461596">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname><given-names>MWN</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Lee</surname><given-names>KM</given-names></name>
<name><surname>Leung</surname><given-names>KS</given-names></name>
</person-group>. <article-title>Articular cartilage increases transition zone regeneration in bone-tendon junction healing</article-title>. <source>Clin Orthop Relat Res</source>. <year>2009</year>;<volume>467</volume>:<fpage>1092</fpage>-<lpage>1100</lpage>.</citation>
</ref>
<ref id="bibr58-0363546512461596">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>JH-C</given-names></name>
</person-group>. <article-title>Mechanobiological response of tendon stem cells: implications of tendon homeostasis and pathogenesis of tendinopathy</article-title>. <source>J Orthop Res</source>. <year>2010</year>;<volume>28</volume>:<fpage>639</fpage>-<lpage>643</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>